MAPT and Alzheimer disease: Additionally, glycogen synthase kinase-3β (GSK3-β) is a key player in AD pathophysiology since dysregulation of this kinase influences tau phosphorylation, Aβ production, memory, neurogenesis, and synaptic function [16].